Canada Life’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-26,202
| Closed | -$23K | – | 2347 |
|
2022
Q4 | $23K | Buy |
26,202
+7,536
| +40% | +$6.62K | ﹤0.01% | 2234 |
|
2022
Q3 | $29K | Buy |
18,666
+680
| +4% | +$1.06K | ﹤0.01% | 2193 |
|
2022
Q2 | $36K | Buy |
17,986
+675
| +4% | +$1.35K | ﹤0.01% | 2124 |
|
2022
Q1 | $42K | Buy |
17,311
+696
| +4% | +$1.69K | ﹤0.01% | 2198 |
|
2021
Q4 | $77K | Buy |
16,615
+651
| +4% | +$3.02K | ﹤0.01% | 2071 |
|
2021
Q3 | $123K | Hold |
15,964
| – | – | ﹤0.01% | 2009 |
|
2021
Q2 | $154K | Buy |
15,964
+26
| +0.2% | +$251 | ﹤0.01% | 1993 |
|
2021
Q1 | $131K | Hold |
15,938
| – | – | ﹤0.01% | 2043 |
|
2020
Q4 | $108K | Buy |
15,938
+8,755
| +122% | +$59.3K | ﹤0.01% | 2097 |
|
2020
Q3 | $80K | Hold |
7,183
| – | – | ﹤0.01% | 2086 |
|
2020
Q2 | $45K | Buy |
+7,183
| New | +$45K | ﹤0.01% | 2251 |
|
2019
Q4 | – | Sell |
-5,186
| Closed | -$11K | – | 2784 |
|
2019
Q3 | $11K | Sell |
5,186
-4,588
| -47% | -$9.73K | ﹤0.01% | 1099 |
|
2019
Q2 | $25K | Hold |
9,774
| – | – | ﹤0.01% | 2564 |
|
2019
Q1 | $46K | Hold |
9,774
| – | – | ﹤0.01% | 2274 |
|
2018
Q4 | $23K | Hold |
9,774
| – | – | ﹤0.01% | 2526 |
|
2018
Q3 | $43K | Hold |
9,774
| – | – | ﹤0.01% | 2426 |
|
2018
Q2 | $69K | Buy |
+9,774
| New | +$69K | ﹤0.01% | 2326 |
|
2017
Q2 | – | Sell |
-5,200
| Closed | -$20K | – | 2552 |
|
2017
Q1 | $20K | Hold |
5,200
| – | – | ﹤0.01% | 2461 |
|
2016
Q4 | $26K | Buy |
+5,200
| New | +$26K | ﹤0.01% | 2457 |
|